Related Experiment Video

Updated: Aug 7, 2026

Detecting Anastasis In Vivo by CaspaseTracker Biosensor
20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

Modulating apoptosis: current applications and prospects for future drug development

H P Deigner1, R Kinscherf

  • 1Institute of Pharmaceutical Chemistry and Institute of Anatomy and Cell Biology III, Im Neuenheimer Feld 364 and 307, Heidelberg, 69120, Germany. Hans-Peter.Deigner@urz.uni-heidelberg.de

Current Medicinal Chemistry
|April 2, 1999
PubMed

Insights

Agents that control programmed cell death (apoptosis) show great promise for treating diseases like cancer and AIDS. This review explores therapeutic targets and strategies, including novel drugs and gene therapy, for various conditions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Apoptosis, or programmed cell death, is a critical cellular process implicated in numerous diseases.
  • Dysregulation of apoptosis is a hallmark of conditions such as cancer, AIDS, neurodegenerative disorders, and ischemic diseases.

Purpose of the Study:

  • To review cellular pathways regulating apoptosis and identify potential therapeutic targets.
  • To discuss current drug development efforts and therapeutic strategies modulating apoptosis for various diseases.
  • To highlight recent advancements and future directions in apoptosis-targeted therapies.

Main Methods:

  • Review of scientific literature on cellular pathways of programmed cell death.
  • Analysis of mechanistic and biochemical aspects of pro- and anti-apoptotic drug development.
  • Discussion of therapeutic approaches including small molecule agents and gene therapy.

Main Results:

  • Identification of key cellular pathways and targets within programmed cell death.
  • Evaluation of novel low molecular weight agents, such as caspase inhibitors.
  • Assessment of gene therapy applications, including p53 and adenovirus vectors for cancer treatment.

Conclusions:

  • Modulating apoptosis offers significant therapeutic potential for a range of diseases.
  • Both small molecule inhibitors and gene-based therapies are promising strategies.
  • Continued research into apoptosis mechanisms will drive future therapeutic innovations.

More Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Quantification of Cytokine-Induced Cell Death in Human Colonic Organoids Using Live Fluorescence Microscopy10:03

Quantification of Cytokine-Induced Cell Death in Human Colonic Organoids Using Live Fluorescence Microscopy

Published on: August 2, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...